Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome

Condition:   Primary Sjogren's Syndrome Intervention:   Drug: LY3361237 Sponsor:   Stanford University Not yet recruiting

Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials